Clinical Trial Update: Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing mono- versus dual antiplatelet therapy after new-generation drug-eluting stent implantation; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Gastrointestinal Injury, Ischemic Heart Disease | Phase 4 | Status: COMPLETED